A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy Volunteers

Phase 1 Completed 56 enrolled Otsuka Pharmaceutical Development & Commercialization, Inc.

RandomizedCrossoverOpen-labelOther

Summary

To assess the multiple-dose pharmacokinetics (PK), safety and tolerability of AVP-786 (deuterated \[d6\] dextromethorphan hydrobromide \[DM\]/quinidine sulfate \[Q\]) in healthy volunteers.

Timeline

Start: 2013-09-01
Primary completion: 2013-11-01
Completion: 2013-11-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AVP-786	Unknown	—	Oral
Comparator	AVP-923	Unknown	—	Oral

Indications

No indication recorded.